Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 6
Submit an article Journal homepage
1,229
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Metformin extended release for the treatment of Type 2 diabetes mellitus

Sherwyn L Schwartz Director, Diabetes and Glandular Disease Clinic and Diabetes and Glandular Disease Research Associates, San Antonio, TX 78229, USA
,
Jacqueline F Wu Senior Medical Writer, Depomed, Inc., 1360 O’Brien Drive, Menlo Park, CA 94025, USA. [email protected]
&
Bret Berner Vice President, Product Development and Chief Scientific Officer, Depomed, Inc., 1360 O’Brien Drive, Menlo Park, CA 94025, USA
Pages 803-809 | Published online: 24 Mar 2006

Bibliography

  • WILD S, ROGLIC G, GREEN A, SICREE R, KING H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 27:1047-1053.
  • AMERICAN DIABETES ASSOCIATION: Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 26:917-932.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. (1993) 329:977-986.
  • UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet (1998) 352:837-853.
  • UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. Br. Med. J. (1998) 317:703-713.
  • SHICHIRI M, KISHIKAWA H, OHKUBO Y, WAKE N: Long-term results of the Kumamoto Study on optimal diabetes control in Type 2 diabetic patients. Diabetes Care (2000) 23(Suppl. 2):B21-B29.
  • UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet (1998) 352:854-865.
  • HOWLETT HC, BAILEY CJ: A risk-benefit assessment of metformin in Type 2 diabetes mellitus. Drug Saf. (1999) 20:489-503.
  • DUNN CJ, PETERS DH: Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs (1995) 49:721-749.
  • GARBER AJ, DUNCAN TG, GOODMAN AM, MILLS DJ, ROHLF JL: Efficacy of metformin in Type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am. J. Med. (1997) 103:491-497.
  • GUSLER G, GORSLINE J, LEVY G et al.: Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. J. Clin. Pharmacol. (2001) 41:655-661.
  • HOU SY, COWLES VE, BERNER B: Gastric retentive dosage forms: a review. Crit. Rev. Ther. Drug Carrier Syst. (2003) 20:459-497.
  • GUSLER GM, HOU SY, CONNOR AL, WILDING IR, BERNER B: Pharmacoscintigraphic evaluation of metformin ER in healthy volunteers. Proceeding of the American Association of Pharmaceutical Scientists Annual Meeting: Salt Lake City, UT, USA (2003).
  • SCHWARTZ S, FONSECA V, BERNER B, CRAMER M, CHIANG Y-K, LEWIN A: Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with Type 2 diabetes. Diabetes Care (2006) 29(4) (In Press).
  • FUJIOKA K, BRAZG RL, RAZ I et al.: Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in Type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies. Diabetes Obes. Metab. (2005) 7:28-39.
  • FUJIOKA K, PANS M, JOYAL S: Glycemic control in patients with Type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clin. Ther. (2003) 25:515-529.
  • WULFFELE MG, KOOY A, DE ZEEUW D, STEHOUWER CD, GANSEVOORT RT: The effect of metformin on blood pressure, plasma cholesterol and triglycerides in Type 2 diabetes mellitus: a systematic review. J. Intern. Med. (2004) 256:1-14.
  • AMERICAN DIABETES ASSOCIATION: Standards of medical care in diabetes – 2006. Diabetes Care (2006) 29(Suppl. 1):S4-S36.
  • RIDDLE M: Combining sulfonylureas and other oral agents. Am. J. Med. (2000) 108(Suppl. 6a):15S-22S.
  • BELL DS, OVALLE F: How long can insulin therapy be avoided in the patient with Type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea? Endocr. Pract. (2000) 6:293-295.
  • UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated Type 2 diabetes (UKPDS 28). Diabetes Care (1998) 21:87-92.
  • DEFRONZO RA, GOODMAN AM: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N. Engl. J. Med. (1995) 333:541-549.
  • HERMANN LS, SCHERSTEN B, BITZEN PO, KJELLSTROM T, LINDGARDE F, MELANDER A: Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care (1994) 17:1100-1109.

Website

  • http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf American Diabetes Association National Diabetes Fact Sheet (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.